Published On : 04 Jul 2017
QYResearchReports.com announces the addition of a new report on the global market for enzyme linked immunosorbent assays, better known as ELISA. The report examines the demand patterns for the ELISA test in the therapeutic regimens of various diseases, illustrating the key diseases likely to drive development of the ELISA market in the coming years. The report profiles the leading players in the global ELISA market in order to provide a clear view of the competitive dynamics of the market, while the regional and product segments of the global ELISA market are also studied in detail in order to provide a granular illustration of the market’s breakdown. The report is titled ‘Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Research Report 2017.’
Enzyme-linked immunosorbent assays are used in the diagnosis of a number of diseases, many of which have assumed prominence in recent years due to their rising prevalence. The ELISA test plays a key role in the diagnosis of diseases such as HIV, which can be called, along with cancer, the most researched disease at present. The rising strength of medical and pharmaceutical sectors in a number of rising countries is likely to play a key role in the growth of the global ELISA market in the coming years, as steady availability of advanced medical infrastructure is necessary for widespread adoption of the ELISA test.
By application, the global ELISA market is segmented into HIV, West Nile Virus, biodefense, and detection of antigens. The robust growth of the medical research sector around HIV due to its growing prevalence among underdeveloped countries in Asia Pacific and Africa is likely to make it the key contributor to the global ELISA market in the coming years. The growing medical research in biodefense and antigens is also likely to remain an important driver for the global ELISA market.
Click to get more details with TOC in a PDF Format: https://www.qyresearchreports.com/sample/sample.php?rep_id=957473&type=E
Regionally, the report looks into the past performance of the ELISA market in developed regions such as North America and Europe, as well as emerging economic powers such as Southeast Asia, China, Japan, and India. The steady support to the medical sector in developed regions is likely to enable their steady dominance in the global ELISA market in the coming years, but the growing acknowledgment of the high volume of unmet demand in emerging regions has driven the healthcare sector in countries such as China, India, and Japan, notwithstanding other dynamic economies in the region such as South Korea, Malaysia, and Indonesia.
The report provides a brief 2012-2017 timeline for each segment of the global ELISA market. Production figures, revenue figures, and pricing trends of each segment are provided in the report, making it a comprehensive repository on the global ELISA market. Further the report provides 2017-2022 forecasts based on a solid analysis of the historical trajectory exhibited by each segment of the global ELISA market.
Key companies examined in the report include BD Biosciences, Thermo Fisher Scientific, BioMerieux, BioLegend, ZEUS Scientific, Bio-Rad Laboratories, Enzo Life Sciences, Shenzhen YHLO Biotech, and EMD Millipore.
Lastly, the report has aimed at equipping readers with decisive findings and a conclusion about the worldwide ELISA Industry.
Top Trending Reports :